Cwm, LLC Exagen Inc. Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
A detailed history of Cwm, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,398 shares of XGN stock, worth $16,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,398Holding current value
$16,398% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
53Shares Held
9.07MCall Options Held
0Put Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$19.9 Million0.18% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6851KShares$9.99 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL719KShares$8.43 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA682KShares$8 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$6.24 Million0.03% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $191M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...